Dichoptic Video Treatment for Amblyopia

October 20, 2021 updated by: Eileen Birch, Retina Foundation of the Southwest

Dichoptic Video Treatment for Amblyopia in Children Age 3-7 Years

  1. To determine whether watching contrast-rebalanced dichoptic videos is effective in improving visual acuity and reducing interocular suppression in amblyopic children
  2. To compare the amount of visual acuity improvement achieved with the videos to tha amount achieved with patching (standard treatment for amblyopia)

Study Overview

Status

Completed

Conditions

Detailed Description

Contrast-rebalanced binocular iPad tablet games (with fellow eye contrast reduced) have been shown to be an effective treatment for amblyopia. However, the games can be challenging for some of the youngest children and boring for some of the older children with amblyopia. To provide additional treatment options using the same contrast-rebalancing approach, we have processed animated videos to allow dichoptic viewing, with full contrast for the amblyopic eye and reduced contrast for the fellow eye. Children will be randomly assigned to watch dichoptic videos (experimental treatment) or patch 2 hours/day every day(standard-of-care amblyopia treatment) for 2 weeks. At the 2-week primary outcome visit, children in the patching group will cross over to the videos and return for a secondary outcome visit at 4 weeks. Families will have the option to continue with the vdeos for up to 8 weeks.

Study Type

Interventional

Enrollment (Actual)

65

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Texas
      • Dallas, Texas, United States, 75231
        • Eileen E Birch

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

3 years to 7 years (CHILD)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • 3 to 7 years old
  • Amblyopic eye visual acuity 20/32-20/125
  • Fellow eye visual acuity 20/16-25
  • Interocular visual acuity difference of at least 2 lines
  • Anisometropia or corrected strabsimus (<5pd)
  • in glasses at least 8 weeks or no change in visual acuity over two visits
  • no prior binocular treatment
  • must be able to see full video screen

Exclusion Criteria:

  • prematurity of 8 weeks or more
  • coexisting ocular or systemic disease
  • developmental delay
  • poor ocular alignment (>=5 pd)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: NONE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
ACTIVE_COMPARATOR: Patching
2 hours per day 7 days per week patching of the fellow eye
covering the fellow eye with an eyepatch to force use of the amblyopic eye
Other Names:
  • occlusion therapy
EXPERIMENTAL: Dichoptic Videos
watching 6 dichoptic videos during each 2 week period
watching contrast-rebalanced dichoptic videos to allow the two eyes to work together

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in visual acuity of the amblyopic eye
Time Frame: Baseline vs 2 weeks
HOTV (preferred) or picture chart
Baseline vs 2 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in visual acuity of the amblyopic eye
Time Frame: Baseline vs 4 weeks, 6 weeks, and 8 weeks
HOTV (preferred) or picture charts
Baseline vs 4 weeks, 6 weeks, and 8 weeks
Change in Stereoacuity
Time Frame: Baseline vs 2, 4, 6, 8 weeks
Randot Preschool Stereoacuity test
Baseline vs 2, 4, 6, 8 weeks
Change in Contrast Balance Index
Time Frame: Baseline vs 2, 4, 6, 8 weeks
Dichoptic Letter chart
Baseline vs 2, 4, 6, 8 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

January 31, 2019

Primary Completion (ACTUAL)

July 6, 2021

Study Completion (ACTUAL)

August 31, 2021

Study Registration Dates

First Submitted

January 29, 2019

First Submitted That Met QC Criteria

January 29, 2019

First Posted (ACTUAL)

January 31, 2019

Study Record Updates

Last Update Posted (ACTUAL)

October 28, 2021

Last Update Submitted That Met QC Criteria

October 20, 2021

Last Verified

October 1, 2021

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Amblyopia

Clinical Trials on patching

3
Subscribe